IL326145A - Inhibitors of cdk2/4/6 kinase - Google Patents
Inhibitors of cdk2/4/6 kinaseInfo
- Publication number
- IL326145A IL326145A IL326145A IL32614526A IL326145A IL 326145 A IL326145 A IL 326145A IL 326145 A IL326145 A IL 326145A IL 32614526 A IL32614526 A IL 32614526A IL 326145 A IL326145 A IL 326145A
- Authority
- IL
- Israel
- Prior art keywords
- cdk2
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363515748P | 2023-07-26 | 2023-07-26 | |
| PCT/US2024/039623 WO2025024707A1 (en) | 2023-07-26 | 2024-07-25 | Inhibitors of cdk2/4/6 kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326145A true IL326145A (en) | 2026-03-01 |
Family
ID=94375493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326145A IL326145A (en) | 2023-07-26 | 2024-07-25 | Inhibitors of cdk2/4/6 kinase |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024298476A1 (en) |
| IL (1) | IL326145A (en) |
| WO (1) | WO2025024707A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112094272A (en) * | 2019-06-18 | 2020-12-18 | 北京睿熙生物科技有限公司 | CDK kinase inhibitors |
| JP2024539620A (en) * | 2021-10-12 | 2024-10-29 | バイオスプライス セラピューティクス インコーポレイテッド | Pyrrolo[2,1-F][1,2,4]triazine derivatives as DYRK1A inhibitors |
| US20250163063A1 (en) * | 2022-01-25 | 2025-05-22 | Kinnate Biopharma Inc. | Inhibitors of cdk4/6 kinase |
-
2024
- 2024-07-25 WO PCT/US2024/039623 patent/WO2025024707A1/en active Pending
- 2024-07-25 IL IL326145A patent/IL326145A/en unknown
- 2024-07-25 AU AU2024298476A patent/AU2024298476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025024707A1 (en) | 2025-01-30 |
| AU2024298476A1 (en) | 2026-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202212146B (en) | Inhibitors of nek7 kinase | |
| IL314397A (en) | Inhibitors of cdk4/6 kinase | |
| EP3806858A4 (en) | SALTS OF KINASE INHIBITORS AND ASSOCIATED COMPOSITIONS | |
| IL309118A (en) | Cdk2 inhibitors | |
| IL288387A (en) | Small molecule inhibitors of nf-kb inducing kinase | |
| IL304728A (en) | Cdk2 inhibitors and methods of using the same | |
| IL320739A (en) | Inhibitors of rock2 | |
| IL307740A (en) | Inhibitors of dna-dependent protein kinase and compositions and uses thereof | |
| CA3265130A1 (en) | Methods of manufacturing kinase inhibitors | |
| IL308346A (en) | Polo like kinase 4 inhibitors | |
| EP4452967A4 (en) | Inhibitors of sars-cov-2 | |
| EP4249489A4 (en) | Heterocyclic compound as diacylglycerol kinase inhibitor and use thereof | |
| IL325596A (en) | Pharmaceutical compositions for inhibitors of nek7 kinase | |
| EP3999064A4 (en) | Inhibitors of tyrosine kinase | |
| IL326145A (en) | Inhibitors of cdk2/4/6 kinase | |
| SG10201909596RA (en) | Synthesis of Tyrosine Kinase Inhibitors | |
| HK40118285A (en) | Inhibitors of cdk4/6 kinase | |
| IL308513A (en) | Imidazole-containing inhibitors of alk2 kinase | |
| EP4161488A4 (en) | Rho kinase inhibitor releasing implants and related methods of use | |
| HK40118888A (en) | Inhibitors of met kinase | |
| CA3297991A1 (en) | Inhibitors of glycogen synthase kinase 3 for therapeutic use | |
| TWI923584B (en) | Inhibitors of nek7 kinase | |
| EP4525876A4 (en) | Oral liquid suspension of pan-raf kinase inhibitor | |
| HK40088585A (en) | Inhibitors of nek7 kinase | |
| IL325620A (en) | Polo-like kinase 1 inhibitors |